Armata Pharmaceuticals, Inc. (NYSE American: ARMP) („Armata“ or the „Company“), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced that the Company will deliver a presentation at Viruses of Microbes 2024, which is being held July 15-19, 2024, in Cairns, Australia.
Home » Armata Pharmaceuticals Announces Presentation at Viruses of Microbes 2024
